Clal Biotechnology (Israel) Financial Diagnostics

CBI -- Israel Stock  

ILS 314.20  0.60  0.19%

Clal Biotechnology Industries Ltd diagnostics interface makes it easy to digest most current publicly released information about Clal Biotechnology as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Clal Biotechnology price relationship with some important fundamental indicators such as market cap and management efficiency.

Clal Biotechnology Note

The company recorded loss per share of 0.39. Clal Biotechnology Industries Ltd had not issued any dividends in recent years. Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. Clal Biotechnology operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. For more info on CLAL BIOTECH please contact the company at 972 3 612 1616 or go to http://www.cbi.co.il.

Clal Biotechnology Alerts

Clal Biotechnology generates negative expected return over the last 30 days
The company reported revenue of 35.05M. Net Loss for the year was (61.27M) with profit before overhead, payroll, taxes, and interest of 11.03M.
CLAL BIOTECH has accumulated about 116.91M in cash with (81.48M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.

Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 512.66M.

Profitablity

The company has Profit Margin (PM) of (174.79) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (208.5) % which suggests for every $100 dollars of sales it generated a net operating loss of -2.08.

Management Efficiency

Clal Biotechnology Industries Ltd has return on total asset (ROA) of (4.59) % which means that it has lost $4.59 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (2.14) % meaning that it generated substantial loss on money invested by shareholders.

Stock Holders for Clal Biotechnology

Technical Drivers

Clal Biotechnology Industries Ltd shows Mean Deviation of 1.18 and Risk Adjusted Performance of (0.12). Clal Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Clal Biotechnology Industries Ltd which can be compared to its rivals. Please confirm Clal Biotechnology Jensen Alpha, Semi Variance and the relationship between Standard Deviation and Value At Risk to decide if Clal Biotechnology is priced correctly providing market reflects its regular price of 314.2 per share.

Clal Biotechnology Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
  
Execute Study
 
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Clal Biotechnology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Clal Biotechnology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Clal Biotechnology Technical and Predictive Indicators

Clal Biotechnology Forecast Models

Did you try this?

Run Cryptocurrency Arbitrage Now

   

Cryptocurrency Arbitrage

Find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage
All  Next Launch Cryptocurrency Arbitrage

Also Currentnly Active

Purchased over 50 shares of
few hours ago
Traded for 58.35
Purchased over 90 shares of
few hours ago
Traded for 32.83
Purchased over 70 shares of
few hours ago
Traded for 34.69
Check also Trending Equities. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Search macroaxis.com